VJVirtual | Cellular therapies for NSCLC

Melissa Johnson, MD, Sarah Cannon Research Institute, Nashville, TN, discusses cellular therapies for the treatment of non-small cell lung cancer (NSCLC) and the associated challenges, including with the identification of eligible patients. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.